Shigeaki Suzuki Selected Research

Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)

3/2020	[Antisynthetase myopathy].
7/2017	Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
1/2017	Skeletal Muscle Involvement in Antisynthetase Syndrome.
1/2017	Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
12/2016	[Autoantibodies of Inflammatory Myopathies: Update].
1/2015	Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
11/2011	[Myositis-specific autoantibodies and their clinical significance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeaki Suzuki Research Topics

Disease

41	Myasthenia Gravis 01/2022 - 04/2003
36	Myositis (Idiopathic Inflammatory Myopathies) 04/2022 - 01/2007
26	Muscular Diseases (Myopathy) 08/2021 - 08/2011
14	Thymoma (Thymic Carcinoma) 01/2021 - 12/2003
11	Neoplasms (Cancer) 01/2021 - 11/2008
11	Muscle Weakness 03/2020 - 08/2011
6	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2007
6	Myocarditis (Carditis) 01/2019 - 08/2007
5	Brain Ischemia (Cerebral Ischemia) 03/2009 - 01/2002
4	Antisynthetase syndrome 01/2022 - 01/2017
4	Inflammation (Inflammations) 09/2021 - 03/2009
4	Deglutition Disorders (Dysphagia) 09/2021 - 10/2016
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020 - 11/2016
4	Joint Diseases (Joint Disease) 03/2020 - 11/2016
4	Inclusion Body Myositis 01/2020 - 12/2016
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 01/2007
4	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 06/2016
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2013 - 01/2012
3	Necrosis 01/2021 - 09/2014
3	Dermatomyositis (Dermatopolymyositis) 01/2021 - 12/2016
3	Exanthema (Rash) 03/2020 - 01/2017
3	Raynaud Disease (Raynaud's Disease) 03/2020 - 01/2017
3	Myelitis 01/2020 - 01/2007
3	Taste Disorders (Taste Disorder) 03/2019 - 04/2013
3	Polymyositis 01/2018 - 11/2016
3	Atrophy 02/2017 - 09/2014
3	Pure Red-Cell Aplasia 09/2013 - 12/2003
3	Central Nervous System Diseases (CNS Diseases) 03/2009 - 01/2007
3	Infarction (Infarctions) 07/2005 - 01/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 01/2020
2	Diplopia (Double Vision) 09/2021 - 06/2019
2	Respiratory Insufficiency (Respiratory Failure) 08/2021 - 10/2016
2	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 02/2017
2	Virus Diseases (Viral Diseases) 01/2020 - 03/2011
2	Nephritis 01/2020 - 01/2013
2	Thymus Hyperplasia 01/2018 - 01/2014
2	Anaphylaxis (Anaphylactic Shock) 01/2018 - 05/2012
2	Lymphoma (Lymphomas) 12/2015 - 01/2015
2	Heart Diseases (Heart Disease) 09/2013 - 04/2013
2	Alopecia Areata 09/2013 - 04/2013
2	Isaacs Syndrome (Neuromyotonia) 09/2013 - 04/2013
2	Disease Progression 06/2012 - 01/2007
2	Migraine Disorders (Migraine) 05/2009 - 02/2007
2	Ischemia 03/2009 - 01/2002
2	Brain Injuries (Brain Injury) 03/2009 - 06/2005

Drug/Important Bio-Agent (IBA)

35	AntibodiesIBA 04/2022 - 01/2007
33	AutoantibodiesIBA 04/2022 - 12/2005
16	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2017
14	Signal Recognition ParticleIBA 08/2020 - 08/2011
12	Cholinergic ReceptorsIBA 01/2021 - 04/2003
9	Oxidoreductases (Dehydrogenase)IBA 08/2020 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2005
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2021 - 12/2005
7	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2020 - 11/2011
7	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 05/2009
6	Creatine Kinase (Creatine Phosphokinase)IBA 09/2021 - 08/2003
6	NivolumabIBA 09/2021 - 01/2017
6	Prednisolone (Predate)FDA LinkGeneric 07/2020 - 01/2014
5	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2011
5	ConnectinIBA 09/2021 - 11/2009
5	SteroidsIBA 07/2021 - 01/2010
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 04/2006
4	anti-titin autoantibodyIBA 09/2021 - 06/2019
4	eculizumab FDA Link 01/2021 - 01/2018
4	Monoclonal AntibodiesIBA 01/2021 - 07/2005
4	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2020 - 01/2015
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019 - 11/2009
4	AntigensIBA 01/2013 - 12/2005
4	Calcineurin InhibitorsIBA 01/2012 - 01/2009
3	pembrolizumabIBA 07/2020 - 06/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2014 - 02/2010
3	AutoantigensIBA 09/2013 - 11/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 03/2009 - 04/2003
2	IpilimumabIBA 09/2021 - 09/2017
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021 - 01/2017
2	glucose-mannose-glucoseIBA 01/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 07/2020 - 11/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 04/2006
2	Immunoglobulin A (IgA)IBA 01/2020 - 04/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020 - 11/2016
2	Ligases (Synthetase)IBA 11/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 01/2013
2	Immunoglobulin M (IgM)IBA 01/2015 - 04/2006
2	GlucocorticoidsIBA 01/2015 - 08/2003
2	EnzymesIBA 01/2015 - 11/2011
2	Muscle Proteins (Muscle Protein)IBA 07/2011 - 01/2011
2	EpitopesIBA 07/2011 - 01/2011
2	CytokinesIBA 03/2009 - 06/2005

Therapy/Procedure

17	Therapeutics 02/2021 - 08/2003
7	Immunotherapy 02/2020 - 11/2008
4	Aftercare (After-Treatment) 09/2021 - 01/2011
4	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2007
3	Plasmapheresis 01/2021 - 01/2011
3	Thymectomy 01/2018 - 12/2003
2	Transplantation 02/2012 - 01/2007
2	Immunomodulation 01/2012 - 11/2009